D-0133-2021 Class II Ongoing

Recalled by Advanced Nutriceuticals, LLC — Indianapolis, IN

Recall Details

THYMOSIN ALPHA, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

CA, CO, FL, IN, KY, OH, TX

Lot #110220200, 1102202009, Exp 12/09/2020; Lot #1105202009, Exp 12/20/2020; Lot #1110202008, Exp 12/10/2020

D-0139-2021 Class II — CEREBROLYSIN, 107.5 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine (November 30, 2020)
D-0132-2021 Class II — BPC-157, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indi (November 30, 2020)
D-0140-2021 Class II — THYMOSIN BETA - 4, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medi (November 30, 2020)
D-0141-2021 Class II — GHK-CU, 10 MG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianap (November 30, 2020)
D-0142-2021 Class II — HIGH DOSE B12, 10 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, (November 30, 2020)
D-0129-2021 Class II — FGL, 10 MG/ML, 3 ML vial, The Guyer Institute of Molecular Medicine, Indianapoli (November 30, 2020)
D-0135-2021 Class II — GHRP, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indiana (November 30, 2020)
D-0143-2021 Class II — LL-37, 2000 MCG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Indian (November 30, 2020)
D-0137-2021 Class II — B12 for Injection, 2 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicin (November 30, 2020)
D-0130-2021 Class II — PT-141, 10 MG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Indianap (November 30, 2020)